Qi‐Man Sun
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Transplantation top 5%
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Cancer Genomics and Diagnostics 3
- Co-authors
- Jia Fan (30 shared papers)Jian Zhou (15 shared papers)Kang Song (9 shared papers)Zheng‐Jun Zhou (4 shared papers)Shao‐Lai Zhou (4 shared papers)Xiaowu Huang (15 shared papers)Yong‐Sheng Xiao (5 shared papers)Zhen‐Bin Ding (4 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Clinical Oncology (2 papers)Journal of Diabetes (2 papers)Cell Death and Disease (2 papers)BioMed Research International (1 paper)
- Partner nations
- ChinaEthiopiaSaudi Arabia
In The Last Decade
Qi‐Man Sun
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 332
- Transplantation 50
- Hepatology 141
- Immunology 189
- Oncology 224
Countries citing papers authored by Qi‐Man Sun
This map shows the geographic impact of Qi‐Man Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi‐Man Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi‐Man Sun more than expected).
Fields of papers citing papers by Qi‐Man Sun
This network shows the impact of papers produced by Qi‐Man Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi‐Man Sun. The network helps show where Qi‐Man Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi‐Man Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 195 | |
| 2 | 2021 | 130 | |
| 3 | 2017 | 82 | |
| 4 | 2022 | 82 | |
| 5 | 2013 | 58 | |
| 6 | 2015 | 52 | |
| 7 | 2018 | 42 | |
| 8 | 2012 | 34 | |
| 9 | 2021 | 30 | |
| 10 | 2017 | 29 | |
| 11 | 2017 | 28 | |
| 12 | 2018 | 28 | |
| 13 | 2021 | 27 | |
| 14 | 2016 | 21 | |
| 15 | 2021 | 21 | |
| 16 | 2015 | 20 | |
| 17 | 2017 | 19 | |
| 18 | 2016 | 18 | |
| 19 | 2023 | 17 | |
| 20 | Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. | 2003 | 17 |
About Qi‐Man Sun
Qi‐Man Sun is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Immunology, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Cancer Genomics and Diagnostics (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), RNA modifications and cancer (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (332 citations), Transplantation (50 citations), Hepatology (141 citations), Immunology (189 citations) and Oncology (224 citations). Qi‐Man Sun has collaborated with scholars based in China, Ethiopia and Saudi Arabia. Frequent co-authors include Jia Fan, Jian Zhou, Kang Song, Zheng‐Jun Zhou, Shao‐Lai Zhou, Xiaowu Huang, Yong‐Sheng Xiao, Zhen‐Bin Ding, Zhi Dai and Xiutao Fu. Their work appears in journals such as PLoS ONE, Journal of Clinical Oncology, Journal of Diabetes, Cell Death and Disease and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.